Evidence map›Paper›PMID 26984967›Full record

ArticleCephalalgia : an international journal of headache2016

Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors' responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?

XiChun Zhang, Andrew M Strassman, Victor Novack, Mitchell F Brin, Rami Burstein

Open access · hybridAbstract read
In one paragraph

Article in Cephalalgia : an international journal of headache, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 129 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. The Use of Botulinum Toxin in the Management of Headache Disorders.Handbook of experimental pharmacology · 2021
    Trial
  5. Article
  6. Observational
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

XiChun ZhangDepartment of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, USA Harvard Medical School, USA.
Andrew M StrassmanDepartment of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, USA Harvard Medical School, USA.
Victor NovackDepartment of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, USA Clinical Research Center, Soroka University Medical Center, Israel Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel.
Mitchell F BrinAllergan plc, Ireland University of California, USA.
Rami BursteinDepartment of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, USA Harvard Medical School, USA rburstei@bidmc.harvard.edu.
Beth Israel Deaconess Medical Center · USHarvard University · USAllergan (Ireland) · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdministration of onabotulinumtoxinA (BoNT-A) to peripheral tissues outside the calvaria reduces the number of days chronic migraine patients experience headache. Because the headache phase of a migraine attack, especially those preceded by aura, is thought to involve activation of meningeal nociceptors by endogenous stimuli such as changes in intracranial pressure (i.e. mechanical) or chemical irritants that appear in the meninges as a result of a yet-to-be-discovered sequence of molecular/cellular events triggered by the aura, we sought to determine whether extracranial injections of BoNT-A alter the chemosensitivity of meningeal nociceptors to stimulation of their intracranial receptive fields. MATERIAL AND

methodsUsing electrophysiological techniques, we identified 161 C- and 135 Aδ-meningeal nociceptors in rats and determined their mechanical response threshold and responsiveness to chemical stimulation of their dural receptive fields with TRPV1 and TRPA1 agonists seven days after BoNT-A administration to different extracranial sites. Two paradigms were compared: distribution of 5 U BoNT-A to the lambdoid and sagittal sutures alone, and 1.25 U to the sutures and 3.75 U to the temporalis and trapezius muscles.

resultsSeven days after it was administered to tissues outside the calvaria, BoNT-A inhibited responses of C-type meningeal nociceptors to stimulation of their intracranial dural receptive fields with the TRPV1 agonist capsaicin and the TRPA1 agonist mustard oil. BoNT-A inhibition of responses to capsaicin was more effective when the entire dose was injected along the suture lines than when it was injected into muscles and sutures. As in our previous study, BoNT-A had no effect on non-noxious mechanosensitivity of C-fibers or on responsiveness of Aδ-fibers to mechanical and chemical stimulation. DISCUSSION: This study demonstrates that extracranial administration of BoNT-A suppresses meningeal nociceptors' responses to stimulation of their intracranial dural receptive fields with capsaicin and mustard oil. The findings suggest that surface expression of TRPV1 and TRPA1 channels in dural nerve endings of meningeal nociceptors is reduced seven days after extracranial administration of BoNT-A. In the context of chronic migraine, reduced sensitivity to molecules that activate meningeal nociceptors through the TRPV1 and TRPA1 channels can be important for BoNT-A's ability to act as a prophylactic.

Indexed as

AnimalsBotulinum Toxins, Type ACapsaicinCranial SuturesMaleMeningesMigraine DisordersMuscle, SkeletalMustard PlantNeuromuscular AgentsNociceptorsPlant OilsRatsRats, Sprague-DawleySensory System AgentsTRPA1 Cation ChannelBotulinum Toxins, Type ACapsaicinmustard oilNeuromuscular AgentsPlant OilsSensory System AgentsTRPA1 Cation ChannelTrpa1 protein, ratTRPC Cation ChannelsTrpv1 protein, ratTRPV Cation Channelschronic migraineHeadachemigraine prophylaxispaintrigeminovascular

Identifiers

PMID26984967
PMCPMC4959034
OpenAlexW2309413820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.